|Phone||+41 61 906 89 50|
|Description||Swiss specialty pharmaceutical company|
|Private Equity, 10/2013 |
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.